Background: A total of 30 endophytic fungi (AAP-PS 1-30) were isolated from the medicinal herb Phyllanthus amarus and screened for the production of Trichothecinol-A. Out of all the endophytic strains screened for Trichothecinol-A production, the culture filtrate of AAP-PS-1 extracted with ethyl acetate yielded Trichothecinol-A extracellularly in appreciable amounts. Trichothecinol-A was purified, quantified and completely characterized by different standard chromatographic and spectroscopic techniques including reverse phase HPLC, 1D and 2D NMR spectroscopy, etc. The compound was tested for antifungal activity against filamentous fungi and yeast, apoptotic activity against B16F10 cells, anticancer activity against MDA-MB-231, HeLa and B16F10 cells as well as antimetastatic activity against MDA-MB-231 cell line.
Background
Endophytic fungi are microorganisms which spend the whole or part of their life-cycle residing symbiotically within the healthy tissues of host plants, inter-and/or intra-cellularly and produce bioactive natural products or drugs and derivatives; meanwhile causing no damage or disease to their hosts [1] .
Owing to the huge developments in the fields of genetic engineering, microbial fermentation technology, etc. the past two decades have seen a major increase in the number of researchers working hard to explore the endophytic fungal diversity, and better understand the relationships between endophytic fungi and their host plants, in an attempt to employ endophytes to obtain valuable compounds of plant origin without exploiting plant parts and to improve the productivity of the ones already being derived by optimizing fermentation conditions to reap benefits of abundant renewable supply [2, 3] . Thus, endophytes hold tremendous promise as an alternative eco-friendly source for efficiently producing valuable bioactive compounds in the future with varied applications in both the research and applied fields of medicine, food industry, agriculture, pest management, etc.
Trichothecenes are a vast group of structurally and chemically related mycotoxins which have a strong impact on the health and well-being of humans, plants and farm animals. These mycotoxins are complex sesquiterpene secondary metabolites produced by fungi belonging to various species of Fusarium, Trichothecium, Trichoderma, Myrothecium, Cephalosporium, Stachybotrys, etc. These mycotoxins are highly stable even during the milling, processing and cooking of food stuffs and thus it's very difficult to get rid of them [4, 5] . It is these trichothecenes which are responsible for the toxicity and spoilage of grains, fruits, vegetables, tubers and other vegetative products worldwide.
Trichothecenes are minute, amphiphatic molecules which are extremely powerful inhibitors of protein synthesis as these have their specific site of action located on a very crucial site on the ribosomal RNA (rRNA), thus interfering with the normal polypeptide chain initiation, elongation and termination [6, 7] . Altering the biological activity of trichothecenes has helped in inducing anti-bacterial, anti-viral, insecticidal, phytotoxic, cytoxic, anti-biotic and anti-tumour properties in the resultant molecules [8] . Konishi et al. reported the trichothecinols A-C, all showing remarkable potential at inhibiting EBV-EA activation induced by TPA (12-O-tetradecanoylphorbol-13-acetate) in Raji cells [9] . Out of these, the most active compound, Trichothecinol-A also suppressed TPA-induced tumour promotion on mouse skin initiated with DMBA (7,12-dimethylbenz[a] anthracene) in a two-stage carcinogenesis experiment.
As part of our ongoing research for plant based drugs using endophytic fungi, we started the isolation and screening of endophytic fungi from medicinal herb Phyllanthus amarus for the production of various beneficial bioactive secondary metabolites and identified a fungal strain Trichothecium sp. which during the present investigation produced only antifungal secondary metabolites against Aspergillus niger. The compound was identified as sesquiterpenoid trichothecene mycotoxin and completely characterized as Trichothecinol-A. P. amarus was used as it is a known astringent, deobstruent, stomachic, diuretic, febrifugal, antiseptic, employed in dropsy and diseases of urinogenital system; its leaves are expectorant, diaphoretic; seeds are carminative, laxative, astringent to the bowels, tonic to the liver, and used as a remedy for bronchitis, earache, griping, opthalmia and ascites [10] [11] [12] [13] . Fresh roots and leaves of this plant have also been reported to be potent remedy for jaundice. All these features made P. amarus a very worthy candidate for our study.
The present work focuses on the isolation, purification and complete characterization of Trichothecinol-A from the endophytic fungus Trichothecium sp. isolated from P. amarus. The anti-fungal, anti-cancer (anti-proliferative), anti-metastatic and apoptotic activities of trichothecinol-A revealed its class-apart potential to be developed as a drug for each mentioned field.
Results and discussion
Isolation, purification and identification of endophytic fungus producing Trichothecinol-A Total thirty endophytic fungi were isolated from leaves and stems of P. amarus and only one culture (AAP-PS-1) isolated from leaves was found to produce Trichothecinol-A extracellularly. Trichothecinol-A producing fungal culture was identified using molecular and morphological approaches. Morphological observations revealed that conidiophores were long, slender, simple, bearing conidia singly, apically, sometimes held together in groups or chains; conidia were hyaline, 2-celled and ovoid to ellipsoid.
Amplification of fungal genomic DNA by primers ITS1 and ITS4 yielded 650 bps fragment (Accession No. JN603460). The analysis of sequence revealed 99.9% identity with that of Trichothecium roseum. Phylogenetic analysis of this strain AAP-PS-1 based on ITS sequences exhibited 98% nucleotide sequence similarity with Trichothecium roseum, the phylogenetically closest validated genus (Figure 1) . The ITS sequence analysis and homology alignment of isolate AAP-PS-1 using BLAST and Clustal-W programme respectively revealed similarity with T. roseum. Also, morphological and cultural studies confirm that the isolate belongs to genus Trichothecium [14] . H spectrum is the presence of a broad peak at~3.48δ which belongs to OH group proton. 13 C NMR spectrum showed the presence of 19 carbons which included two carbonyls (198.52δ, 168.05δ), four olefinic (148δ to 119δ) and thirteen sp 3 carbons in the region 85δ to 5δ. The assignments of the 1 H and 13 C spectra are presented in Table 1 and Figure 2 . The spectral details are included as Supporting information (Additional file 1: Figures S5-S12 , Tables S1  and S2 ). The NMR spectral features are found to match very well with the one reported by Konishi et al. [9] .
Antifungal activity of Trichothecinol-A
In contrary to earlier reports [9] , we for the first time demonstrated antifungal activity of Trichothecinol-A against a range of filamentous fungi and yeast. Trichothecinol-A exhibited moderate activity against yeast Cryptococcus albidus var diffluens NCIM 3372 up to 20 μg/mL. MIC and IC 50 values were determined as described below (Table 2 ). Dose response curves of Trichothecinol-A are included as supporting information (Additional file 1: Figure S13 ). Significant increase in the sub G 0 population was observed in Trichothecinol-A treated cells in a time dependent manner. 500 nM of Trichothecinol-A had 12.7% sub G 0 population as compared to 3.88% in vehicle control in 12 h. However, cells treated with 500 nM of Trichothecinol-A for 24 h resulted in an increase of apoptotic fraction to 52.96% versus 16.68% in vehicle control.
Enhanced migratory capacity is one of the hall marks of highly invasive tumor cells. Inhibition of cancer cell migration could be an effective means of preventing cancer metastasis, thereby enabling confinement of primary tumors in manageable form, making surgical options more viable [15] . During opening phase of the metastatic cascade, cancer cells penetrate into surrounding tissues and blood vessels and it has been shown to be the rate limiting step in an experimental model [16] . Therefore, inhibition of the cell migration represents a potential therapeutic approach for the treatment of tumor metastasis. Here, we studied the inhibitory effect of Trichothecinol-A in MDA-MB-231 cell migration at various concentrations. Percentage of wound closure was determined by the difference in area covered by migrated cells in control versus treated with Trichothecinol-A at 0 or 18 h. The results show that the 500 nM of Trichothecinol-A was able to inhibit wound closure by 50% where as 2.5 and 5 μM concentrations of Trichothecinol-A inhibited migration up to 75% as compared to vehicle control (Figure 5a & b) .
Because, the common approach of chemotherapy is to decrease the growth rate (cell division) of the cancer cells, the side effects are seen in bodily systems that naturally have a rapid turnover of cells including skin, hair, gastrointestinal and bone marrow. These healthy, normal cells also end up damaged by the chemotherapy program. Hence, it's reasonable to look out for compounds with antimetastatic activity which could be further developed as lead against cancer metastasis. As, Trichothecinol-A is showing promising antimetastatic activity against human breast carcinoma (MDA-MBA-231) and antiproliferative activity against skin carcinoma (B16F10) at nanomolar concentration, therefore, it can be used as scaffold in drug Figure 2 .
discovery programme to synthesize analogues with better specificity and favourable pharmacological properties. Further efforts are needed to modify the compound to remove sites of non specific toxicity and understand the mechanism by which this compound inhibits cancer cell growth and migration.
Materials and methods
Isolation, purification, identification and screening of endophytic fungi for the production of Trichothecinol -A A total of 30 endophytic fungi (AAP-PS 1-30) were isolated from medicinal herb P. amarus as described elsewhere [17] [18] [19] . Each fungal culture was checked for purity and transferred to agar slants by hyphal tip as well as single spore isolation method [17, 20] . Production of Trichothecinol-A by endophytic fungi was studied by a two stage fermentation procedure [21] . The flasks containing MGYP media (Malt extract 0.3%, Glucose 1%, Yeast extract 0.3%, Peptone 0.5%) were inoculated with agar plugs of mycelium from 7 day old slants. The inoculated flasks were incubated at 28°C on rotary shaker at 180 rpm for 6 days. These cultures were used as seed culture (first stage). For Trichothecinol -A production, 20 mL seed culture was transferred to 500 mL Erlenmeyer flask containing modified S7 medium [21] . The flasks were incubated at 28°C for 30 days as stationary culture (second stage). After incubation, the cultures were harvested and passed through sterile cotton to separate mycelial mat from culture filtrate. The culture filtrate was lyophilized and extracted thrice with equal volumes of ethyl acetate. The extracts were pooled and dried with anhydrous sodium sulphate and concentrated at 40°C under reduced pressure to yield crude extract. The antifungal activity and a method developed by Sorenson et. al. was used to detect Trichothecinol-A in crude extract [22] . The culture (AAP-PS-1) producing Trichothecinol-A was used for further studies.
Identification of endophytic fungus producing Trichothecinol-A by morphological and molecular methods
Identity of endophytic fungal culture (AAP-PS-1) producing Trichothecinol-A was established by using morphological and molecular approaches. For studying the morphological features, the fungus was grown on potato dextrose agar (potato 25%, dextrose 2%, agar 2%). Morphological characteristics of the fungus like mycelia, conidiophores and conidia were microscopically studied (Carl Ziess Axiovert 25 Inverted microscope and Nikon Eclipse E200). The genomic DNA was isolated by salting out method with little modification [23] . Sonication for a period of 5 min was done before lysozyme treatment. ITS region of genomic DNA was amplified using ITS1 TCCGTAGGTGAACCTGCGG (forward) and ITS4 TCCTCCGCTTATTGATATGC (reverse) primers. PCR products were eluted from agarose gel by protocol described in Axygen™ gel elution kit, Biosciences USA. The purified PCR product was ligated with pGEM-T vector and transformed into competent E.coli XL-1 cells [24] . Plasmid containing the insert was isolated using alkaline lysis method [24] . The cloned fragments were sequenced using Sangers dideoxy method using ABI prism big dye terminator cycle sequencing kit from ABI system [25] . The sequence obtained was further analysed for its homology by using online tool nucleotide BLAST. The multiple sequence alignments were carried out using CLUSTAL-W and phylogenetic inferences were obtained using the maximum-likelihood method within MEGA program. The bootstrap of consensus tree was inferred from 500 replicates. The evolutionary distances were computed using the Kimura2 parameter. All positions containing gaps and missing data were eliminated from the dataset (Complete deletion option). Acremonium strictum were used as an out-group.
Purification and quantification of Trichothecinol-A
Trichothecinol-A was purified using preperative TLC and RP-HPLC. TLC plates coated with 0.5 mm thickness of silica were used for preparative TLC. Approximately 0.5 mL of crude sample dissolved in methanol was loaded on to plate and developed in hexane: ethyl acetate (2:1) solvent system. The developed plates were air dried and exposed to iodine vapours. Individual bands were scrapped, eluted with ethyl acetate, concentrated in vacuo and tested for antifungal activity against Aspergillus niger by agar well diffusion method. Out of eight bands, second and fifth band showed good antifungal activity. The second band was further processed for purification by analytical RP HPLC. HPLC analysis was performed on a Waters model using a C 18 symmetry pack column with the flow rate of 0.5 mL/min and eluted with a 40 minutes gradient of water: actonitrile (95: 5). The Trichothecinol-A was detected by a dual mode wavelength detector set at 220 nm and 240 nm.
Quantification of Trichothecinol-A by HPLC
Stock solution of different concentrations (1 mg/ml, 3 mg/ml, 5 mg/ml and 10 mg/ml) of a purified Trichothecinol-A was prepared in HPLC grade acetonitrile. 10 μl of each stock solution was injected in HPLC to generate a standard graph of peak area v/s concentration. Then, the known volume of (10 μl) crude dissolved in HPLC grade acetonitrile containing unknown concentration of Trichothecinol-A was analysed by HPLC and the peak area of Trichothecinol-A containing peak was compared to standard graph to calculate its concentration.
Complete characterization of Trichothecinol-A
UV-visible spectroscopy measurements were carried out on Jasco dual beam spectrophotometer (model V-570) operated at resolution of 1 nm. Molecular mass of the compound was determined by M/S Applied Biosystems API QSTAR pulsar (ESI-MS) mass spectrometer. HRMS analysis was carried out using mass spectrometry instrument (model -Autoconcept) by direct injection probe with resolving power of 6000. FTIR spectroscopy measurements of purified compound taken in Kbr pellet were carried out using a Perkin-Elmer spectrum one instrument. Spectrometer was used in the diffuse reflectance mode of resolution 2 cm
. All the NMR measurements were carried out on Bruker AV 500 spectrometer operating at 500 MHz and 125 MHz, respectively for H HMBC experiments were performed under standard conditions using a 5 mm BBFO probe at ambient temperature (~25°C). Chemical shifts in the 1 H spectra were referenced to residual CHCl 3 peak (7.26 ppm), while 13 C spectra were referenced to CDCl 3 (77.0 ppm).
Antifungal assay
The purified compound was analyzed for antifungal activity against different plant pathogenic, saprophytic fungi and yeast. Antifungal assay was performed in microtiter plates as reported earlier [26, 27] . Fungal spores were removed from a 4 days old culture, transferred to YM broth (Glucose 1%, Malt extract 0.3%, Yeast extract 0.3%) and adjusted to 2x10 5 spores or cells/mL. The compound was diluted in DMSO to get desired concentrations. 50 μL aliquots of spores were mixed with different concentrations of compounds (10 to 100 μg/mL in 10 μL of DMSO). Final volume was adjusted by adding 140 μL YM media. Total assay volume was 200 μL. The plates were incubated at 28°C for 48 h.
OD 600 measurements
The OD 600 measurements were carried out on microtiter plate reader (Bio-Rad xMark). The MIC was determined as the lowest concentration of Trichothecinol-A that completely inhibits visible growth of the microorganism. The dose response curves were obtained by plotting concentration of compound v/s% growth inhibition. The IC 50 values were determined as the concentration of Trichothecinol-A that could show 50% of maximum inhibition.
Cell culture and reagents
Human breast adenocarcinoma (MDA-MB-231), human cervical cancer (HeLa) and murine melanoma (B16F10) cell lines were obtained from American Type Culture Collection and were grown in L-15, DMEM and RPMI media respectively, supplemented with 10% fetal bovine serum and 100 U/mL Penicillin and Streptomycin (Invitrogen). All cells were grown in humidified atmosphere with or without 5% CO 2 and 95% air at 37°C. Tetrazolium dye and Propidium Iodide was purchased from Sigma.
Cell viability assay
MDA-MB-231, HeLa and B16F10 cells (2x10 4 ) were seeded in 96 well plates. Cells were treated with Trichothecinol-A for 24 h with indicated concentration.
Treatment was terminated by removing media and MTT [3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide] (0.5 mg/ml) was added. After 4 h, crystals were dissolved in isopropanol and A 570 was recorded.
Flow cytometry analysis
Flow cytometry experiments were performed as described earlier [28] . Murine melanoma B16F10 cells were treated with indicated concentrations of Trichothecinol-A in RPMI media supplemented with 10% fetal bovine sera for 12 and 24 h. DNA analysis was done and cell undergoing apoptosis were determined following propidium iodide staining (FACS Calibar, Becton Dickinson).
Wound assay
Wound assay was performed with post confluent MDA-MB-231 cells as described [29] . Briefly, uniform sized wounds were made. MDA-MB-231 cells were treated with 2.5 μM of Trichothecinol-A. DMSO was used as vehicle control. After 18 h, photographs were taken and the area of migrated cells was quantified using Image Pro Plus 6.0 software (Nikon).
Statistical analysis
The data reported in cytotoxicity and cell migration experiments are expressed as mean ± S.E. Statistical differences were determined by Student's t test. The p value < 0.05 was considered significant.
Conclusion
We for the first time have isolated a sesquiterpene viz. Trichothecinol-A produced by an endophytic fungus Trichothecium sp. isolated from medicinal herb Phyllanthus amarus. The compound was purified and characterized by using different chromatographic and spectroscopic techniques. Being non proteinaceous in nature, this compound holds the promise of potent antiproliferative and most importantly antimetastic lead, if suitably modified by employing combinatorial chemistry approaches to enhance its drug like properties. Trichothecinol-A exhibits appreciable antimetastatic activity against human breast carcinoma (MDA-MBA-231) and antiproliferative activity against skin carcinoma (B16F10) at nanomolar concentrations. Also, Trichothecinol-A showed good antifungal activity against Cryptococcus albidus var diffluens (NCIM 3371 and 3372) and Penicillium expansum (NCIM 939). Therefore, the above compound could be used as scaffold in drug discovery programmes to synthesize effective and more specific analogues which can be further developed as drugs. Further studies are required to understand the mechanism by which this compound inhibit cancer cell growth and metastasis.
Additional file
Additional file 1: Figure S1 . HPLC was carried out using waters separation module. Figure S2 : UV-visible spectroscopy measurements were carried out on Perkin Elmer spectrophotometer (model lambda -750) operated at resolution of 1nm. Maximum Uv absorption was observed at 251nm in ethyl acetate. Figure S3 : FTIR spectroscopy measurements of purified compound taken in Kbr pellet were carried out using a PerkinElmer spectrum one instrument. Figure S4 : Molecular mass of the compound was determined by M/S Applied Biosystems API QSTAR pulsar (ESI-MS) mass spectrometer. 
